Stock AMRN AMARIN CORPORATION PLC
Add to a list
To use this feature you must be a member
Log inSign up

All News Amarin Corporation plc

Equities

AMRN

US0231112063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.8786 USD -0.53% Intraday chart for Amarin Corporation plc -4.20% +0.99%
Apr. 19 European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down MT
Apr. 18 European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
GL
Amarin Announces Results of Annual General Meeting of Shareholders
GL
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
MT
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
GL
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
MT
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
GL
New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
AQ
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
AQ
Amarin Corporation plc Announces New Reduce-It® Analyses Show Vascepa®/Vazkepa® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
CI
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
GL
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower
MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
MT
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
GL
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
AQ
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMRN Stock
  4. News Amarin Corporation plc